(Q34733937)

4 August 2017

1 reference

title

Advances in systemic therapy of small cell cancer of the lung (English)

1 reference

4 August 2017

1 reference

G A Daniels

1

1 reference

4 August 2017

A A Adjei

series ordinal

2

1 reference

4 August 2017

publication date

1 August 2001

1 reference

Expert Review of Anticancer Therapy

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

211-221

1 reference

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

Topotecan: a review of its efficacy in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.1.2.211

21 January 2018

Identifiers

DOI

10.1586/14737140.1.2.211

1 reference

4 August 2017

1 reference